THOMPSON DAVIS & CO., INC. - ARROWHEAD PHARMACEUTICALS IN ownership

ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 161 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q4 2018. The put-call ratio across all filers is 1.05 and the average weighting 0.1%.

Quarter-by-quarter ownership
THOMPSON DAVIS & CO., INC. ownership history of ARROWHEAD PHARMACEUTICALS IN
ValueSharesWeighting
Q3 2018$55,000
-52.6%
2,871
-66.4%
0.12%
-56.5%
Q2 2018$116,000
+34.9%
8,553
-28.5%
0.28%
+21.6%
Q1 2018$86,000
+290.9%
11,969
+102.5%
0.23%
+336.5%
Q4 2017$22,0005,9110.05%
Other shareholders
ARROWHEAD PHARMACEUTICALS IN shareholders Q4 2018
NameSharesValueWeighting ↓
ELEMENT CAPITAL MANAGEMENT LLC 142,649$618,0000.25%
ING GROEP NV 808,229$3,500,0000.07%
A.R.T. Advisors, LLC 232,470$1,006,0000.05%
OppenheimerFunds, Inc. 3,000,000$12,990,0000.02%
Edge Wealth Management LLC 10,000$43,0000.01%
First Allied Advisory Services, Inc. 61,000$264,0000.01%
BRIDGEWAY CAPITAL MANAGEMENT, LLC 200,000$866,0000.01%
MILLENNIUM MANAGEMENT LLC 1,272,138$5,508,0000.01%
D. E. Shaw & Co., Inc. 971,768$4,208,0000.01%
Virtu Financial LLC 18,008$78,0000.00%
View complete list of ARROWHEAD PHARMACEUTICALS IN shareholders